Please login to the form below

Not currently logged in
Email:
Password:

ulcerative colitis

This page shows the latest ulcerative colitis news and features for those working in and with pharma, biotech and healthcare.

Communiqué: big wins for obesity and sugar tax campaigners

Communiqué: big wins for obesity and sugar tax campaigners

This entry described a live ‘broadcast’meeting that provided education around excess steroid use, a standard treatment for ulcerative colitis. ... Meanwhile, Aurora Healthcare Communications’ Travel with IBD campaign for Japanese pharma group

Latest news

More from news
Approximately 19 fully matching, plus 106 partially matching documents found.

Latest Intelligence

  • Taking a lean and careful approach Taking a lean and careful approach

    ulcerative colitis, type 1 diabetes and inflammatory bowel disease.

  • Making digital health personal Making digital health personal

    Personalisation: A case study. This case study is of a digital health support programme that improved persistence of people with ulcerative colitis.

  • Deal Watch January 2017 Deal Watch January 2017

    Assembly Biosciences. Allergan. Exclusive global licence . 2 pc candidates for ulcerative colitis (ABI-M201) and Crohn's disease plus 2 compounds for IBS.

  • Forging a path in specialty care Forging a path in specialty care

    Adcetris (for Hodgkin Lymphoma), Entyvio (for ulcerative colitis and Crohn's Disease) and future compound Ninlaro (an oral protease inhibitor for relapsed/refractory multiple myeloma) which was approved by the FDA

  • Biosimilars - the same, but different? Biosimilars - the same, but different?

    The first months of 2015 also saw it approve Remsima and Inflectra for use on the NHS to treat moderately to severely active ulcerative colitis after the failure of conventional therapy.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics